SenzaGen

📍 Lund, Sweden🗓 Founded 2010👥 20 employees💰 Last funded 2022
Biotechnology🌐 senzagen.com
Website LinkedIn
SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® test platform, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in SenzaGen?
SenzaGen has 1 investors on record on gritt.io.
When did SenzaGen last raise funding?
The most recent investment in SenzaGen recorded on gritt.io was in 2022.
When was SenzaGen founded?
SenzaGen was founded in 2010.
What industry is SenzaGen in?
SenzaGen operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is SenzaGen based?
SenzaGen is headquartered in Lund, Sweden.